Non-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries. Br J Clin Pharmacol 2002;54(2):171-7.De Ponti F, Poluzzi E, Vaccheri A et al. (2002) Non-anti- arrhythmic drugs prolonging the QT interval: considerable use in seven countries. Br J Clin Pharmacol...
Lin YL, Chan, K. Pharmacokinetic and pharmacodynamic characterization of non-antiarrhythmic QT-prolonging drugs associated wtih torsade de pointes. Drug Information Journal 2008;42:211-9.Lin Y-L, Chan K. Pharmacokinetic and pharmacodynamic characterization of non-antiarrhythmic QT-prolonging drugs ...
Compared to no use of QT-prolonging drugs, use of non-cardiac QT-prolonging drugs (Netherlands: cases: 3.0%, controls: 1.9%; Denmark: cases: 14.9%, controls: 7.5%) was associated with increased OHCA risk (Netherlands: OR 1.37 [95% CI: 1.03-1.81]; Denmark: OR 1.63 [95% CI: 1.57-...
Pharmacokinetic and pharmacodynamic characterization of non-antiarrhythmic QT-prolonging drugs associated wtih torsade de pointes. Drug Information Journal 2008;42:211-9.Lin Y-L, Chan K. Pharmacokinetic and pharmacodynamic characterization of non-antiarrhythmic QT-prolonging drugs associated with torsades de...